Skip to content
EU Startups News
  • Funding
  • Launch
  • Partnership
  • Acquisition
  • Policy
  • Exit & IPO

Quibim

Spanish AI Company Quibim Launches Breast Cancer Detection Tool for MRI Imaging Across Europe and UK

July 2, 2026 by Marco Bianchi

Quibim, a Spanish AI medical imaging company, has launched QP-Breast in Europe and the UK, the first AI tool for detecting breast cancer via MRI after obtaining regulatory approvals. The tool accurately identifies suspicious lesions and generates detailed reports.

Categories Launch Tags Artificial Intelligence, Healthtech, Quibim, Spain Leave a comment
Browse by Country

Latest

Manchester AI Platform Revnu Raises €2.6 Million to Expand Sales Automation Across Europe and USOct 1, 2026
Copenhagen AI Transcription Startup Good Tape Secures Fresh Funding to Launch Insight-Linking PlatformOct 1, 2026
London AI Recruiting Platform Metaview Raises €53.1 Million in Series C RoundOct 1, 2026
Luxembourg Cybersecurity Startup Osavul Secures €8.5M Series A to Expand Enterprise and Defence OperationsOct 1, 2026
Cluj-Napoca Transport Software Startup AtruX Launches Free Subscription Campaign for Small Fleet OperatorsOct 1, 2026

EU Markets

European Financial Markets Weekly: Billion-Dollar Raises, Banking Stress Tests, and What It All Means for Your StartupSep 25, 2026
Europe's Financial Markets Are Shifting — Here's What Startup Founders Need to Know This WeekSep 18, 2026
ECB Rate Hike, Banking M&A, and a Crypto Security Storm: What Europe's Financial Markets Mean for Startups This WeekSep 11, 2026
European Markets Signal Both Opportunity and Caution for Startups This WeekSep 4, 2026

EU Startups News
• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.